https://youtu.be/RnqCE2wfLhU
Although there are now multiple medications available to treat schizophrenia, many gaps still exist as a barrier to treatment success resulting in lower quality of life for this patient population. Shared decision-making and collaborating with patients and caregivers can help address some of these gaps, however this model is complex and takes time.
Presented by the CME Institute of Physicians Postgraduate Press, Inc. and supported by educational grants from Alkermes, Inc. and Sunovion Pharmaceuticals, Inc.
Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.